VYXEOS

Serial Number 88265407
Registration 5821009
700

Registration Progress

Application Filed
Jan 17, 2019
Under Examination
Approved for Publication
May 14, 2019
Published for Opposition
May 14, 2019
Registered
Jul 30, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-07-30) (Grace Period Filing)
Due: Jan 30, 2026 Grace Period - 178 days
Original deadline was Jul 30, 2025 (overdue)

Trademark Image

VYXEOS

Basic Information

Serial Number
88265407
Registration Number
5821009
Filing Date
January 17, 2019
Registration Date
July 30, 2019
Published for Opposition
May 14, 2019
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 30, 2019
Registration
Registered
Classes
005

Rights Holder

Celator Pharmaceuticals, Inc.

03
Address
3170 Porter Drive
Palo Alto, CA 94304

Ownership History

Celator Pharmaceuticals, Inc.

Original Applicant
03
Ewing, NJ

Celator Pharmaceuticals, Inc.

Owner at Publication
03
Ewing, NJ

Celator Pharmaceuticals, Inc.

Original Registrant
03
Palo Alto, CA

Legal Representation

Attorney
Timothy D. Sitzmann

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-07-30)
Due Date
July 30, 2025
Grace Period Ends
January 30, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

19 events
Date Code Type Description Documents
Jun 26, 2025 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jul 30, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
May 26, 2021 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Feb 19, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 19, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 19, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 19, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 19, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 30, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 15, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 15, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 14, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 14, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 24, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 29, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 29, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 21, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Feb 9, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 21, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cancer
First Use Anywhere: Aug 11, 2017
First Use in Commerce: Aug 11, 2017

Additional Information

Design Mark
The mark consists of the word "VYXEOS" in purple with an ascending and descending curved blue line intersecting the letter "X".
Color Claim
The color(s) purple and blue is/are claimed as a feature of the mark.

Classification

International Classes
005